Peer Review History
| Original SubmissionMarch 15, 2020 |
|---|
|
PONE-D-20-03722 Prevalence and associated factors of premenstrual syndrome among women of reproductive age group in Ethiopia: systematic review and meta-analysis PLOS ONE Dear Dr. Geta, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 06 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Nülüfer Erbil, Ph.D, Prof. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Title: Prevalence and associated factors of premenstrual syndrome among women of reproductive age group in Ethiopia: systematic review and meta-analysis The study by Teshome Gensa Geta et al, on premenstrual syndrome is of importance as it affects women globally who are in their reproductive age. The quality of women’s life during PMS is greatly affected by cluster of emotional, physical, and behavioural symptoms. These symptom expressions can vary between a few days to couple of weeks. As PMS is associated with mood and behavioural symptoms, a study by Kimberly Ann Yonkers et al.,(Lancet. 2008 Apr 5; 371(9619): 1200–1210) clearly described its connection with the brain and further suggested two different methods to treat these symptoms. In the present study, the authors have claimed to have conducted the first systematic review and meta-analysis study on the prevalence and associated factors of PMS in Ethiopia. The authors have pooled various published original research articles from Ethiopia (until December 25, 2019) on PMS and its associate factors as their dataset. The quality of the dataset had been assessed using the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) while data analysis had been performed using the STATA software version 14. From the 33 original research articles, using various criteria the authors have chosen to use the data only from 9 studies which has the total sample size of 3373 and considered for further analysis. The authors show that the pooled prevalence of PMS in Ethiopia was 53%(95% CI: 4064, 65.36). Further, high heterogeneity had also been detected in their study samples (I2 = 98.4%, p < 0.001). The authors have taken various factors into consideration like sample size, year of publication and quality of study to investigate the possible source of heterogeneity using statistical methods, however, the results were found to be insignificant. Eager test too showed insignificant P-value of P = 0538. In order to reduce the heterogeneity, the authors have also performed the subgroup analysis based on study settings and found that the pooled prevalence of PMS among university students was 53.87% (95% CI: 40.97, 67.60). The result shows that though significant heterogeneity had been observed, there was some improvement of heterogeneity at the university level. The authors have also studied various associated factors of PMS and show that, age, irregular menses, duration of menses, menstrual pattern has a statistically significant association with PMS among some of the high school and university students. Further age at menarche also had a significant association with PMS. In contrast a study done at Mekelle high school female students showed that income, cigarette smoking, alcohol, and contraceptive use had no significant association with PMS. Based on the analysis and the results, the authors conclude that pooled prevalence of PMS in Ethiopia was 53% indicating that half of the Ethiopian women were suffered from PMS in their reproductive years. This number may vary across countries due to various factors such as socio-demographic, individual life-style, marital status etc. The pooled odds ratio showed that age at menarche, menstrual pattern and hormonal contraceptive use had statistically insignificant association with PMS. The limitation of this study was restricted only with high school and university students who live in Oromia, Amhara, Benishangul-Gumuz and Tigrai region of Ethiopia. The authors have carried out a significant work in understanding the PMS in different regions of Ethiopia among high school and university students. I hope the authors may work with the larger data in the future which could also include working women, married/unmarried in their dataset. Further, as PMS symptoms are mostly associated with mood and behaviour, I would also suggest the authors to discuss and co-relate their findings with the receptors expressed in the brain, such as serotonin and its associated receptors. PS: I have a small concern, the Figure 1 ‘Fig 1: flow chart showing articles selection strategy‘ have a very high similarity to the Figure 1 from the previously published article by Ashraf Direkvand-Moghadam et al., J Clin Diagn Res. 2014 Feb; 8(2): 106–109. I have provided the link to this article below: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972521/ Kindly make changes in your Figure 1 before it’s been accepted for publication. Further, I would also suggest the author to proof read the manuscript with a native English speaker to improve standard of English in the manuscript. This manuscript may be accepted for publication in the current form after the suggested corrections as their objective of the had been addressed. My best wishes to all the authors. Thank you. Reviewer #2: This analysis – designed to estimate the pooled prevalence of Premenstrual Syndrome, PMS, and its associated factors in Ethiopia – followed a reasonable strategy to review published studies. It concludes that that the majority of reproductive aged high school and college aged women do experience PMS. The paper needs to be strengthened to render that conclusion credible. Essential ms changes that should be made before consideration for publication include 1. Offer the reader a clear definition of what constitutes PMS since no disease is associated per the definition offered. Well-known hormonal shifts have been clearly defined in the literature. a. The current definition of PMS is too vague and could apply to any fertile aged prescient woman who undergoes the well characterized sequential peak in progesterone approximately 7 days after ovulation and its subsequent decline to undetectable levels by menses onset. Since estrogen levels also plunge as P levels do, the assertion that P declines are responsible for PMS should be explained or omitted. b. How is the “syndrome” diagnosed? Self-administered questionnaire then scored using standard procedures? i. Can the authors provide a supplement for interested readers to review? c. Does a health care worker make an assessment after interview? d. Does a woman have to complain of the problem for it to be identified as PMS? e. Who makes the judgment that this is a “syndrome” rather than a normal variation in energy and mood cycles? 2. An English language editor is essential because the word usage is frequently erroneous. For example, these underlined words do not make sense and the reader is left guessing what the authors probably mean: a. Line 57 each of the three precede menstrual cycles b. Line 61 The… meta-analysis did worldwide c. Line 69-70 with joining in heavy duties… initial menarche d. Line 71 being sexually active among students e. Line 73-4 may outcome f. Line 78 has given on it. g. Line 103 .for studies that were not shown the outcome of h. Line 114 after a brief discussion on the tool. i. Line 117 those studies with less than 5 scores j. Line 195 A study at high school students k. Line 212 In contrary to this study… 3. Outcome of Interest a. Independent variables chosen should be improved i. Age at menarche was simply divided into two groups: those 12 or younger and those older. This seems too gross a division to hope to find an effect of age on PMS if avg age of menarche in Ethiopia mirrors the US at about 12 yrs. It would be more meaningful to divide groups into at least 3 or better yet 5 age groups: very early, early, average, mildly late, and very late. If you did, it would be interesting to learn about the relationship between the syndrome and the age ii. Menstrual pattern as regular or irregular should be clearly explained: did women keep records of their menses that scholars extracted data from? Recall has been shown to be not useful in multiple studies that showed strong relationships between menstrual pattern and hormonal outcomes. 4. Results a. Figures 2, 3 and 4 each need a legend to explain the scale on the x axis. For example, on Figure 4, I wonder how a prevalence could be less than zero. Or why -84.7 is even labelled? b. The study characteristics Tools should be explained so that readers can understand how they measure their “findings.” (Please see point 1a above). c. The prevalence outcome beginning on line 170 is clearly stated. Once the reader knows how the measures were obtained, the prevalence [in more than half the women] can be better understood to evaluate the importance of the findings. d. Beginning line 227 It would be interesting to learn what kind of contraceptives were used in the study that did and the study that did not find a relationship to PMS. Some drugs flatten out the hormonal environment; others elevate and depress hormonal levels in sequence. 5. The strength of the study statement is good. As well as the limitations. Except for the misuse of English in line 273: were suffered from PMS. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-03722R1 Prevalence and associated factors of premenstrual syndrome among women of reproductive age group in Ethiopia: systematic review and meta-analysis PLOS ONE Dear Dr. Geta, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 17 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Nülüfer Erbil, Ph.D, Prof. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: My best wishes to the authors and I wish the authors may carry out the study with a larger sample size across all over Ethiopia in the future. Reviewer #2: The authors did a fine job of revising the manuscript and I have only a few remaining comments. I will not need to review the paper again and am fine with publishing it once these are considered. 1. 2 typos need to be fixed: first on line 60: ‘relieved’ is the correct spelling; not relived; then on line 64 add an “s” to pluralize the word “cycle” 2. The quality assessment paragraph beginning with line 115 is nice but there seems to be no mention of the relative quality assessments of the 9 studies that are analyzed. The careful reader will wonder which of the 9 were high-quality papers and whether these produced a more consistent outcome than putting them all in one basket. I assumed there was no quality restriction for inclusion. But I am left uncertain. The results did not provide this information. Or I missed it? 3. Line 295, I suggest “suffering” is not an appropriate term. We really cannot tell whether cyclic variation in mood, and energy which alters ones “normal activity” causes pain and suffering. In fact, the energy swing itself might be part of the human condition of what constitutes normal. Women are not robots and cyclic variation in energy and mood sufficient to alter how one engages in the work and other activities is a rational response to hormonal and metabolic change. I would suggest using the word “experiencing” rather than “suffering”. Considering that about half of women experience these swings might suggest that medicalizing such experience is not such a wise idea. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Winnifred Cutler [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Prevalence and associated factors of premenstrual syndrome among women of reproductive age group in Ethiopia: systematic review and meta-analysis PONE-D-20-03722R2 Dear Dr. Geta, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Nülüfer Erbil, Ph.D, Prof. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-03722R2 Prevalence and associated factors of premenstrual syndrome among women of the reproductive age group in Ethiopia: systematic review and meta-analysis Dear Dr. Geta: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Nülüfer Erbil Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .